Concepedia

Dahlia Sano

DS

Statistics

Publications

7

Citations

195

H-Index

7

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Wayne State University

The Barbara Ann Karmanos Cancer Institute

Dahlia Sano is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and lymphoma treatment response.

Publications per year

2017–2021

7

Publications

7

Nivolumab induced myxedema crisis

Uqba Khan, Humaira Rizvi, Dahlia Sano et al. · Journal for ImmunoTherapy of Cancer · 2017 · 61 citations · Full text

Medicine, Immunology, Oncology +15

Platelets and renal failure in the SARS-CoV-2 syndrome

Muhanad Taha, Dahlia Sano, Samer Najeeb Hanoudi et al. · Platelets · 2020 · 29 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +15

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

Yingjun Wang, Vasantha Lakshmi Gali, Zijun Y. Xu‐Monette et al. · Neoplasia · 2021 · 29 citations · Full text

Medicine, Genetics, Molecular Genetics +17

CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

Krish Patel, Jeffrey A. Zonder, Dahlia Sano et al. · Blood · 2021 · 29 citations

Medicine, Oncology, Pharmacology +15

Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma

Dahlia Sano, Loretta J. Nastoupil, Nathan Fowler et al. · Blood · 2018 · 24 citations

Medicine, Hematology, Oncology +14

1–5 of 7